｜ Set as homepage ｜ Favorite ｜ 中文版 ｜
About Us Products News & Press Contact Us Careers Resources
News & Press
  News & Press
 
News & Press
News & Press >
  2009/06/05 Oneness Biotech Co. was granted the bio-pharmaceutical company status
  2009/04/20 ''DCB-WH1 New Drug Development – the Treatment of Chronic Diabetic Foot Ulcers'' was granted government support by MOEA ITDP
  2008/10/23 Received Drug Sales Permit from the Taipei City Health Bureau
  2008/09/20 Oneness Biotech Co., officially relocated to Nangang Software Park, Building D, 7F.
  2008/09/09 Capitals raised up to NT$551 million dollars
  2008/09/08 Oneness Biotech Board Meeting
  2008/09/04 DCB-WH1, a phase II clinical trial for diabetic foot ulcers was approved as ’Index Case of Critical Path Program’ by CDE
  2008/06/09 Oneness Biotech Co. was incoporated

Copyright © 2012  Oneness Biotech Co., Ltd　
Add：7F.-1, No.3-1, Yuanqu St., Nangang Dist., Taipei City 115, Taiwan (R.O.C.)　
Tel：+886-2-2655-8098　Fax：886-2-2655-8099

   About Us ︱ Products︱ News & Press︱ Contact Us︱ Careers︱ Resources
網站系統訊息　 Designed By uGear 優吉兒 網頁設計